Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-26

Clinical Trial Update: Microporous Polysaccharide Hemospheres Epistaxis [NA]

View source ↗

Summary

Emory University-sponsored clinical trial investigating microporous polysaccharide hemospheres for epistaxis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Microporous Polysaccharide Hemospheres

Snippet

Sponsor: Emory University | Conditions: Epistaxis | NA | Status: WITHDRAWN